Paul Jeng
Stock Analyst at Guggenheim
(2.93)
# 1,676
Out of 5,046 analysts
4
Total ratings
100%
Success rate
40%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Paul Jeng
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMCR Immunocore Holdings | Assumes: Neutral | n/a | $32.92 | - | 1 | Sep 18, 2025 | |
| IMTX Immatics | Initiates: Buy | $16 | $10.18 | +57.17% | 1 | Sep 18, 2025 | |
| CNTX Context Therapeutics | Initiates: Buy | $5 | $1.09 | +358.72% | 1 | Sep 18, 2025 | |
| IDYA IDEAYA Biosciences | Initiates: Buy | $50 | $31.86 | +56.94% | 1 | Sep 18, 2025 |
Immunocore Holdings
Sep 18, 2025
Assumes: Neutral
Price Target: n/a
Current: $32.92
Upside: -
Immatics
Sep 18, 2025
Initiates: Buy
Price Target: $16
Current: $10.18
Upside: +57.17%
Context Therapeutics
Sep 18, 2025
Initiates: Buy
Price Target: $5
Current: $1.09
Upside: +358.72%
IDEAYA Biosciences
Sep 18, 2025
Initiates: Buy
Price Target: $50
Current: $31.86
Upside: +56.94%